[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 176″]
Last time we talked with David Muller, PhD, he was leaving Avedro to start a new company. Two years later, Dr. Muller’s company, Allotex, has raised capital from a strategic investor and is preparing to enter clinical trials in Europe. In this OIS Podcast, Muller tells us why Allotex may succeed where others have fallen short. For more on Allotex, watch this Companies to Watch presentation.